Guardant Health (GH) Depreciation & Amortization (CF) (2017 - 2026)

Guardant Health has disclosed Depreciation & Amortization (CF) across 10 years of filings, most recently posting $9.4 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $9.4 million, down 7.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.9 million (down 7.08% YoY), and the FY2025 annual result was $39.7 million, down 6.25% from the prior year.
• Depreciation & Amortization (CF) came in at $9.4 million for Q1 2026 at Guardant Health, down from $10.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $11.0 million in Q3 2023 to a low of $7.2 million in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $10.2 million (2025), against an average of $10.0 million.
• Across the five-year window, Depreciation & Amortization (CF) jumped 76.89% in 2022 and declined 11.23% in 2025, its largest moves.
• Guardant Health's Depreciation & Amortization (CF) stood at $10.2 million in 2022, then advanced by 6.87% to $10.9 million in 2023, then decreased by 3.81% to $10.5 million in 2024, then retreated by 3.86% to $10.0 million in 2025, then decreased by 6.05% to $9.4 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $9.4 million (Q1 2026), $10.0 million (Q4 2025), and $9.4 million (Q3 2025), per Business Quant data.